Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1γ

OBJECTIVE: Since dermatomyositis (DM) is associated with an increased risk of malignancy, accurate identification of patients likely to harbor cancers is important. Using immunoprecipitations from radiolabeled cell lysates, several groups recently showed that anti–transcription intermediary factor 1...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Fiorentino, David F., Chung, Lorinda S., Christopher-Stine, Lisa, Zaba, Lisa, Li, Shufeng, Mammen, Andrew L., Rosen, Antony, Casciola-Rosen, Livia
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2013
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4073292/
https://ncbi.nlm.nih.gov/pubmed/24037894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.38093
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia